Onychomycosis.
The prevalence and clinical types of onychomycosis and diagnostic methods are reviewed in this article. The need for correct identification of the causative organism is emphasized. The use of oral and topical therapeutic agents is outlined, with specific emphasis on relevant research data and potential side effects of these agents. Sections on the potential hazard of nail dust, onychomycosis in HIV-infected patients, and the long-term management of onychomycosis are also included.
Hoffman
A F
AF
Department of Basic Sciences and Podiatric Medicine, California College of Podiatric Medicine, San Francisco, USA.
Driver
V R
VR
D017088:AIDS-Related Opportunistic Infections / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology; D000279:Administration, Cutaneous; D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000935:Antifungal Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004391:Dust; D006801:Humans; D008875:Middle Aged; D016273:Occupational Exposure; D014009:Onychomycosis / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology
D000935:Antifungal Agents; D004391:Dust